Pain :: Over $650M Paid in OxyContin Settlements
OxyContin manufacturer Purdue Pharma and the company?s top executives have agreed to pay settlement fees in excess of $650 million to the Federal government, 26 states, and the District of Columbia.
Medical
Stem Cell :: U.S. Supreme Court Decision Boosts Stem Cell Patent Challenge
A U.S. Supreme Court decision in favor of KSR International Corp. on Monday strengthens challenges against overreaching human embryonic stem cell patents held by an affiliate of the University of Wisconsin, the Foundation for Taxpayer and Consumer Rights (FTCR) and the Public Patent Foundation (PUBPAT) said today.
Bleeding Disorder :: Loss of gene involved in clot formation may explain bleeding disorder
Patients with the syndrome leukocyte adhesion deficiency (LAD) III suffer from recurrent infections and an increased tendency to bleed. The exact defect responsible for this disease remains unclear.
Heart :: Protecting the heart against mechanical stress
Enlargement or overgrowth of heart cells known as cardiomyocytes ? cardiac hypertrophy ? is a common event in many heart diseases, and occurs in an effort to restore stresses on the heart wall to normal levels.
Immunity :: Mutation in the protein TACI underlies common variable immunodeficiency
Common variable immunodeficiency (CVID) encompasses a varied group of immunodeficiency syndromes characterized by B cell defects, low immunoglobulin levels, and recurrent bacterial infections.
Stent :: Panel offers expert analysis on causes, prevention of stent thrombosis
Over the last year, it’s been rare to utter the word “stent” without at least thinking “thrombosis,” an uncommon but serious complication that’s been on the minds of interventional cardiologists and patients alike.
Heart :: Novel catheter technique successfully patches holes in the heart
A novel catheter technique for patching holes in the heart may make it possible for many patients to avoid surgery altogether and others to regain enough strength to safely undergo surgical repair at a later date, according to a study reported at the 30th annual Scientific Sessions of the Society for Cardiovascular Angiography and Interventions, May 9-12, 2007, in Orlando, Fla.
Stent :: ENDEAVOR III Trial reports key findings on new-generation stent
New data reported at the 30th Annual Scientific Sessions of the Society for Cardiovascular Angiography and Interventions, May 9-12, 2007, in Orlando, Fla., will offer clues to the fate of a new-generation drug-eluting stent that is vying for a place in the treatment of coronary artery disease.
Heart :: CIMA Scientists investigate a molecule for diagnosing hypertensive cardiopathy
Scientists from the Center for Applied Medical Research from the University of Navarra investigate whether cardiotrophin 1, a molecule that can be measured in blood, can be used as a diagnostic marker for hypertensive cardiopathy.
Avian Flu :: New host species for avian influenza identified
In a new study published online in the open-access journal PLoS Pathogens, Dr. Vincent J. Munster, of Erasmus Medical Center, Rotterdam, and colleagues identify new host species for avian influenza A virus (H5N1) and provide important information on the distinctions between the ecology and epidemiology of various global strains of the virus.